187 related articles for article (PubMed ID: 37574016)
1. In vitro anti-bactrical activity and its preliminary mechanism of action of the non-medicinal parts of Sanguisorba officinalis L. against Helicobacter pylori infection.
Chen P; Chen M; Peng C; Yan J; Shen X; Zhang W; Yuan Y; Gan G; Luo X; Zhu W; Yao M
J Ethnopharmacol; 2024 Jan; 318(Pt B):116981. PubMed ID: 37574016
[TBL] [Abstract][Full Text] [Related]
2. In vitro anti-Helicobacter pylori activity of Syzygium aromaticum and the preliminary mechanism of action.
Peng C; Sang S; Shen X; Zhang W; Yan J; Chen P; Jiang C; Yuan Y; Zhu W; Yao M
J Ethnopharmacol; 2022 Apr; 288():114995. PubMed ID: 35032584
[TBL] [Abstract][Full Text] [Related]
3. In-vitro anti-Helicobacter pylori activity and preliminary mechanism of action of Canarium album Raeusch. fruit extracts.
Yan J; Peng C; Chen P; Zhang W; Jiang C; Sang S; Zhu W; Yuan Y; Hong Y; Yao M
J Ethnopharmacol; 2022 Jan; 283():114578. PubMed ID: 34464702
[TBL] [Abstract][Full Text] [Related]
4. In vitro anti-bacterial activity and network pharmacology analysis of Sanguisorba officinalis L. against Helicobacter pylori infection.
Shen X; Zhang W; Peng C; Yan J; Chen P; Jiang C; Yuan Y; Chen D; Zhu W; Yao M
Chin Med; 2021 Apr; 16(1):33. PubMed ID: 33865425
[TBL] [Abstract][Full Text] [Related]
5. Anti-Helicobacter pylori and urease inhibition activities of some traditional medicinal plants.
Amin M; Anwar F; Naz F; Mehmood T; Saari N
Molecules; 2013 Feb; 18(2):2135-49. PubMed ID: 23434867
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of Southern African medicinal plants on Helicobacter pylori and Lactobacillus species.
Dinat S; Orchard A; Van Vuuren S
J Ethnopharmacol; 2024 Aug; 330():118238. PubMed ID: 38663780
[TBL] [Abstract][Full Text] [Related]
7. The Activity of Liposomal Linolenic Acid Against
Wang Y; Wu S; Wang L; Wang Y; Liu D; Fu Y; Xie Y
Front Cell Infect Microbiol; 2022; 12():865320. PubMed ID: 35656035
[No Abstract] [Full Text] [Related]
8. In Vitro Antioxidant and Anti-
Kim S; Oh S; Noh HB; Ji S; Lee SH; Koo JM; Choi CW; Jhun HP
Molecules; 2018 Nov; 23(11):. PubMed ID: 30453560
[TBL] [Abstract][Full Text] [Related]
9. A scoping review of African natural products against gastric ulcers and Helicobacter pylori.
Dinat S; Orchard A; Van Vuuren S
J Ethnopharmacol; 2023 Jan; 301():115698. PubMed ID: 36174808
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia.
Hu S; Zhou Y; Deng Y; Bo Y; Chen X; Yang W; Shi R; Zhao W; Hou Z; Hu J; Liu J; Zhang X; Yong H; Wang P; Li F; Qi H; Wang X; Jin L; Cui T; Yong H; Li X; Yang B; Yu Y; Ma B; Fu L; Wang X; Ma Z; Tang N; You Y; Guo J; Yu X; Yao L; Gao R; Li Y; Xin R; Liu J; Cao Z; Li H; Ma L; Ma S; Cao Y; Tang Y; Liu J; Hao Q; Li X; Li X; Mu R; Niu M; Su X; Gao H
Helicobacter; 2023 Jun; 28(3):e12960. PubMed ID: 37042045
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021.
Shao Y; Lin Y; Wang B; Miao M; Ye G
Helicobacter; 2022 Oct; 27(5):e12920. PubMed ID: 35939548
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.
Nestegard O; Moayeri B; Halvorsen FA; Tønnesen T; Sørbye SW; Paulssen E; Johnsen KM; Goll R; Florholmen JR; Melby KK
PLoS One; 2022; 17(4):e0265322. PubMed ID: 35442962
[TBL] [Abstract][Full Text] [Related]
13. Cinnamaldehyde: An effective component of Cinnamomum cassia inhibiting Helicobacter pylori.
Li CY; Liao LJ; Yang SX; Wang LY; Chen H; Luo P; Huang GR; Huang YQ
J Ethnopharmacol; 2024 Aug; 330():118222. PubMed ID: 38663778
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activity and molecular modelling of fosfomycin combinations with some antibiotics against multidrug resistant Helicobacter pylori.
Abouwarda AM; Ismail TA; Abu El-Wafa WM; Faraag AHI
World J Microbiol Biotechnol; 2022 Apr; 38(6):102. PubMed ID: 35486219
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance patterns of Helicobacter pylori in North Israel - A six-year study.
Azrad M; Vazana D; On A; Paritski M; Rohana H; Roshrosh H; Agay-Shay K; Peretz A
Helicobacter; 2022 Dec; 27(6):e12932. PubMed ID: 36110057
[TBL] [Abstract][Full Text] [Related]
16. Gastroprotective action of the extract of Corydalis yanhusuo in Helicobacter pylori infection and its bioactive component, dehydrocorydaline.
Wu H; Sun Q; Dong H; Qiao J; Lin Y; Yu C; Li Y
J Ethnopharmacol; 2023 May; 307():116173. PubMed ID: 36681166
[TBL] [Abstract][Full Text] [Related]
17. Correlation between Chemical Profile of Georgian Propolis Extracts and Their Activity against
Widelski J; Okińczyc P; Suśniak K; Malm A; Bozhadze A; Jokhadze M; Korona-Głowniak I
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771040
[No Abstract] [Full Text] [Related]
18. Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea.
Lee JW; Kim N; Choi SI; Jang JY; Song CH; Nam RH; Lee DH
Helicobacter; 2023 Feb; 28(1):e12939. PubMed ID: 36478622
[TBL] [Abstract][Full Text] [Related]
19. Valorization of
Ayoub IM; Abdel-Aziz MM; Elhady SS; Bagalagel AA; Malatani RT; Elkady WM
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432065
[No Abstract] [Full Text] [Related]
20. Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial.
Liou JM; Jiang XT; Chen CC; Luo JC; Bair MJ; Chen PY; Chou CK; Fang YJ; Chen MJ; Chen CC; Lee JY; Yang TH; Yu CC; Kuo CC; Chiu MC; Chen CY; Shun CT; Hu WH; Tsai MH; Hsu YC; Tseng CH; Chang CY; Lin JT; El-Omar EM; Wu MS;
Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):228-241. PubMed ID: 36549320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
